Biomarkers of Response to Cyclin D-CDK4/6 Targeted Therapies in Cancer
- 专利权人:
- The Regents of the University of California
- 发明人:
- Dennis Slamon,Richard Finn,Dylan Conklin,Erika von Euw
- 申请号：
- US16369963
- 公开号：
- US20190292605A1
- 申请日:
- 2019.03.29
- 申请国别(地区):
- US
- 年份:
- 2019
- 代理人:
- 摘要：
- Provided herein are biomarkers indicating sensitivity or resistance to Cyclin D-CDK4/6 inhibitor therapy in cancer and methods of use.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- Biomarkers of Response to Cyclin D-CDK4/6 Targeted Therapies in Cancer
- BIOMARKERS FOR RESPONSE TO TYROSINE KINASE PATHWAY INHIBITORS IN CANCER
- METHODS OF IDENTIFYING RESPONSES TO MAP KINASE INHIBITION THERAPY
- Molecular Biomarkers for Predicting Response to Tyrosine Kinase Inhibitors in Lung Cancer
- INTRACELLULAR KINASE SIK3 ASSOCIATED WITH RESISTANCE AGAINST ANTI-TUMOUR IMMUNE RESPONSES, AND USES THEREOF
